Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743451361> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2743451361 abstract "<p><strong>Background: </strong>Acute puerperal metritis (APM) is a potentially life threatening, painful disease and is often treated with third-generation cephalosporins (Machado et al., 2014; Stojkov et al., 2015). An increasing antibiotic resistance is well documented and associated with decreasing clinical efficacy, animal welfare and economic consequences (Thomson et al., 2004). Hence, there is the need to evaluate alternative therapies to antibiotics.</p><p><strong>Objective:</strong> The objective of this study was to assess the efficacy of ketoprofen for the treatment of APM compared with ceftiofur hydrochloride.</p><p><strong>Materials and Methods:</strong> A total of 610 dairy cows from 6 farms in Germany were enrolled. Inclusion criteria was a rectal temperature (RT) ≥ 39.5 °C and a reddish-brown fetid vaginal discharge within the first 10 DIM. Cows meeting the inclusion criteria were randomly allocated to treatment with ketoprofen (3 mg/kg of body weight, n = 300) or treatment with ceftiofur (1 mg/kg of body weight, n = 310), both administered on 3 consecutive days. Rectal temperature was recorded daily for a period of 7 days after enrollment. Cows that showed RT ≥ 39.5 °C on day 4 to 7 after inclusion received an extended treatment (extT) with ceftiofur for 3 (ketoprofen group) or 2 (ceftiofur group) more days. Between 21 and 40 DIM cows were examined with the metricheck device and vaginal discharge was categorized on a 5-point scale according to the presence of pus.</p><p><strong>Results:</strong> A total of 52 cows (35 from ketoprofen group, 17 from ceftiofur group) were excluded from analysis due to missing protocol compliance (n = 37) or concurrent disease (n = 15). Cows initially treated with ketoprofen had higher odds of extT than cows treated with ceftiofur (61% vs 31%, OR 3.47, P < 0.01, n = 558). Occurrence of purulent vaginal discharge (PVD) was similar for both treatment groups. However, cows with extT had 2.12 (P < 0.01, n = 438) times the odds of PVD than cows without extended treatment. Treatment group did not affect milk yield, first artificial insemination pregnancy risk, time to first AI and time to pregnancy.</p><p><strong>Conclusions:</strong> The results indicate that although cows initially treated with ketoprofen were more likely to receive extT, fewer doses of ceftiofur (1.83) were required compared with cows initially treated with ceftiofur (3.63). Consequently, there is considerable potential of reducing antimicrobial treatment by implementing a treatment protocol starting with ketoprofen.</p><br /> <img src=https://www.veterinaryevidence.org/rcvskmod/icons/oa-icon.jpg alt=Open Access />" @default.
- W2743451361 created "2017-08-17" @default.
- W2743451361 creator A5091816444 @default.
- W2743451361 date "2017-08-10" @default.
- W2743451361 modified "2023-09-24" @default.
- W2743451361 title "Efficacy of Non-steroidal Anti-inflammatory Drugs for the Treatment of Acute Puerperal Metritis in Dairy Cows" @default.
- W2743451361 doi "https://doi.org/10.18849/ve.v2i3.143" @default.
- W2743451361 hasPublicationYear "2017" @default.
- W2743451361 type Work @default.
- W2743451361 sameAs 2743451361 @default.
- W2743451361 citedByCount "0" @default.
- W2743451361 crossrefType "journal-article" @default.
- W2743451361 hasAuthorship W2743451361A5091816444 @default.
- W2743451361 hasBestOaLocation W27434513611 @default.
- W2743451361 hasConcept C126322002 @default.
- W2743451361 hasConcept C140793950 @default.
- W2743451361 hasConcept C22641795 @default.
- W2743451361 hasConcept C2776659692 @default.
- W2743451361 hasConcept C2779234561 @default.
- W2743451361 hasConcept C2780122547 @default.
- W2743451361 hasConcept C2780744026 @default.
- W2743451361 hasConcept C2781384322 @default.
- W2743451361 hasConcept C42972112 @default.
- W2743451361 hasConcept C501593827 @default.
- W2743451361 hasConcept C54355233 @default.
- W2743451361 hasConcept C64778159 @default.
- W2743451361 hasConcept C71924100 @default.
- W2743451361 hasConcept C86803240 @default.
- W2743451361 hasConcept C89423630 @default.
- W2743451361 hasConcept C98274493 @default.
- W2743451361 hasConceptScore W2743451361C126322002 @default.
- W2743451361 hasConceptScore W2743451361C140793950 @default.
- W2743451361 hasConceptScore W2743451361C22641795 @default.
- W2743451361 hasConceptScore W2743451361C2776659692 @default.
- W2743451361 hasConceptScore W2743451361C2779234561 @default.
- W2743451361 hasConceptScore W2743451361C2780122547 @default.
- W2743451361 hasConceptScore W2743451361C2780744026 @default.
- W2743451361 hasConceptScore W2743451361C2781384322 @default.
- W2743451361 hasConceptScore W2743451361C42972112 @default.
- W2743451361 hasConceptScore W2743451361C501593827 @default.
- W2743451361 hasConceptScore W2743451361C54355233 @default.
- W2743451361 hasConceptScore W2743451361C64778159 @default.
- W2743451361 hasConceptScore W2743451361C71924100 @default.
- W2743451361 hasConceptScore W2743451361C86803240 @default.
- W2743451361 hasConceptScore W2743451361C89423630 @default.
- W2743451361 hasConceptScore W2743451361C98274493 @default.
- W2743451361 hasLocation W27434513611 @default.
- W2743451361 hasLocation W27434513612 @default.
- W2743451361 hasOpenAccess W2743451361 @default.
- W2743451361 hasPrimaryLocation W27434513611 @default.
- W2743451361 hasRelatedWork W1743665424 @default.
- W2743451361 hasRelatedWork W1975403685 @default.
- W2743451361 hasRelatedWork W2012126208 @default.
- W2743451361 hasRelatedWork W2074612184 @default.
- W2743451361 hasRelatedWork W2110548483 @default.
- W2743451361 hasRelatedWork W2121593440 @default.
- W2743451361 hasRelatedWork W2121701363 @default.
- W2743451361 hasRelatedWork W2127907644 @default.
- W2743451361 hasRelatedWork W2130925344 @default.
- W2743451361 hasRelatedWork W2183845452 @default.
- W2743451361 hasRelatedWork W2396460524 @default.
- W2743451361 hasRelatedWork W2417478871 @default.
- W2743451361 hasRelatedWork W2585172199 @default.
- W2743451361 hasRelatedWork W2804443267 @default.
- W2743451361 hasRelatedWork W2816864503 @default.
- W2743451361 hasRelatedWork W2885631815 @default.
- W2743451361 hasRelatedWork W2913999236 @default.
- W2743451361 hasRelatedWork W2998847123 @default.
- W2743451361 hasRelatedWork W3161421830 @default.
- W2743451361 hasRelatedWork W3195962672 @default.
- W2743451361 isParatext "false" @default.
- W2743451361 isRetracted "false" @default.
- W2743451361 magId "2743451361" @default.
- W2743451361 workType "article" @default.
%20is%20a%20potentially%20life%20threatening%2C%20painful%20disease%20and%20is%20often%20treated%20with%20third-generation%20cephalosporins%20(Machado%20et%20al.%2C%202014%3B%20Stojkov%20et%20al.%2C%202015).%20An%20increasing%20antibiotic%20resistance%20is%20well%20documented%20and%20associated%20with%20decreasing%20clinical%20efficacy%2C%20animal%20welfare%20and%20economic%20consequences%20(Thomson%20et%20al.%2C%202004).%20Hence%2C%20there%20is%20the%20need%20to%20evaluate%20alternative%20therapies%20to%20antibiotics.%26lt%3B%2Fp%26gt%3B%26lt%3Bp%26gt%3B%26lt%3Bstrong%26gt%3BObjective%3A%26lt%3B%2Fstrong%26gt%3B%20The%20objective%20of%20this%20study%20was%20to%20assess%20the%20efficacy%20of%20ketoprofen%20for%20the%20treatment%20of%20APM%20compared%20with%20ceftiofur%20hydrochloride.%26lt%3B%2Fp%26gt%3B%26lt%3Bp%26gt%3B%26lt%3Bstrong%26gt%3BMaterials%20and%20Methods%3A%26lt%3B%2Fstrong%26gt%3B%20A%20total%20of%20610%20dairy%20cows%20from%206%20farms%20in%20Germany%20were%20enrolled.%20Inclusion%20criteria%20was%20a%20rectal%20temperature%20(RT)%20%E2%89%A5%2039.5%20%C2%B0C%20and%20a%20reddish-brown%20fetid%20vaginal%20discharge%20within%20the%20first%2010%20DIM.%20Cows%20meeting%20the%20inclusion%20criteria%20were%20randomly%20allocated%20to%20treatment%20with%20ketoprofen%20(3%20mg%2Fkg%20of%20body%20weight%2C%20n%20%3D%20300)%20or%20treatment%20with%20ceftiofur%20(1%20mg%2Fkg%20of%20body%20weight%2C%20n%20%3D%20310)%2C%20both%20administered%20on%203%20consecutive%20days.%20Rectal%20temperature%20was%20recorded%20daily%20for%20a%20period%20of%207%20days%20after%20enrollment.%20Cows%20that%20showed%20RT%20%E2%89%A5%2039.5%20%C2%B0C%20on%20day%204%20to%207%20after%20inclusion%20received%20an%20extended%20treatment%20(extT)%20with%20ceftiofur%20for%203%20(ketoprofen%20group)%20or%202%20(ceftiofur%20group)%20more%20days.%20Between%2021%20and%2040%20DIM%20cows%20were%20examined%20with%20the%20metricheck%20device%20and%20vaginal%20discharge%20was%20categorized%20on%20a%205-point%20scale%20according%20to%20the%20presence%20of%20pus.%26lt%3B%2Fp%26gt%3B%26lt%3Bp%26gt%3B%26lt%3Bstrong%26gt%3BResults%3A%26lt%3B%2Fstrong%26gt%3B%20A%20total%20of%2052%20cows%20(35%20from%20ketoprofen%20group%2C%2017%20from%20ceftiofur%20group)%20were%20excluded%20from%20analysis%20due%20to%20missing%20protocol%20compliance%20(n%20%3D%2037)%20or%20concurrent%20disease%20(n%20%3D%2015).%20Cows%20initially%20treated%20with%20ketoprofen%20had%20higher%20odds%20of%20extT%20than%20cows%20treated%20with%20ceftiofur%20(61%25%20vs%2031%25%2C%20OR%203.47%2C%20P%20%26amp%3Blt%3B%200.01%2C%20n%20%3D%20558).%20Occurrence%20of%20purulent%20vaginal%20discharge%20(PVD)%20was%20similar%20for%20both%20treatment%20groups.%20However%2C%20cows%20with%20extT%20had%202.12%20(P%20%26amp%3Blt%3B%200.01%2C%20n%20%3D%20438)%20times%20the%20odds%20of%20PVD%20than%20cows%20without%20extended%20treatment.%20Treatment%20group%20did%20not%20affect%20milk%20yield%2C%20first%20artificial%20insemination%20pregnancy%20risk%2C%20time%20to%20first%20AI%20and%20time%20to%20pregnancy.%26lt%3B%2Fp%26gt%3B%26lt%3Bp%26gt%3B%26lt%3Bstrong%26gt%3BConclusions%3A%26lt%3B%2Fstrong%26gt%3B%20The%20results%20indicate%20that%20although%20cows%20initially%20treated%20with%20ketoprofen%20were%20more%20likely%20to%20receive%20extT%2C%20fewer%20doses%20of%20ceftiofur%20(1.83)%20were%20required%20compared%20with%20cows%20initially%20treated%20with%20ceftiofur%20(3.63).%20Consequently%2C%20there%20is%20considerable%20potential%20of%20reducing%20antimicrobial%20treatment%20by%20implementing%20a%20treatment%20protocol%20starting%20with%20ketoprofen.%26lt%3B%2Fp%26gt%3B%26lt%3Bbr%20%2F%26gt%3B%20%26lt%3Bimg%20src%3Dhttps%3A%2F%2Fwww.veterinaryevidence.org%2Frcvskmod%2Ficons%2Foa-icon.jpg%20alt%3DOpen%20Access%20%2F%26gt%3B%22){kind=link}